The global Opioids market was valued at US$ 10050 million in 2023 and is anticipated to reach US$ 14730 million by 2030, witnessing a CAGR of 5.5% during the forecast period 2024-2030.

Opioids Market

Opioids are a class of drugs that include the illegal drug heroin, synthetic opioids such as fentanyl, and pain relievers available legally by prescription, such as oxycodone (OxyContin®), hydrocodone (Vicodin®), codeine, morphine, and many others. These drugs are chemically related and interact with opioid receptors on nerve cells in the body and brain.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Opioids, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Opioids.

Report Scope

The Opioids market size, estimations, and forecasts are provided in terms of sales volume (MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Opioids market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Opioids manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Opioids Market Report

Report Metric	Details
Report Name	Opioids Market
Accounted market size in 2023	US$ 10050 million
Forecasted market size in 2030	US$ 14730 million
CAGR	5.5%
Base Year	2023
Forecasted years	2024 - 2030
Segment by Type	Oxycodone Hydromorphone Codeine Fentanyl Other
Segment by Application	Pain Relief Anesthesia Cough Suppression Diarrhea Suppression Deaddiction Others
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Teva, Purdue Pharma, Mallinckrodt, Amneal Pharma, Collegium, J&J, Endo, Pfizer, INSYS, Mylan, Hikma, Egalet
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Opioids manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Opioids in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Opioids Market growing?

Ans: The Opioids Market witnessing a CAGR of 5.5% during the forecast period 2024-2030.

What is the Opioids Market size in 2030?

Ans: The Opioids Market size in 2030 will be US$ 14730 million.

Who are the main players in the Opioids Market report?

Ans: The main players in the Opioids Market are Teva, Purdue Pharma, Mallinckrodt, Amneal Pharma, Collegium, J&J, Endo, Pfizer, INSYS, Mylan, Hikma, Egalet

What are the Application segmentation covered in the Opioids Market report?

Ans: The Applications covered in the Opioids Market report are Pain Relief, Anesthesia, Cough Suppression, Diarrhea Suppression, Deaddiction, Others

What are the Type segmentation covered in the Opioids Market report?

Ans: The Types covered in the Opioids Market report are Oxycodone, Hydromorphone, Codeine, Fentanyl, Other

1 Opioids Market Overview

1.1 Product Overview and Scope of Opioids

1.2 Opioids Segment by Type

1.2.1 Global Opioids Market Value Comparison by Type (2024-2030)

1.2.2 Oxycodone

1.2.3 Hydromorphone

1.2.4 Codeine

1.2.5 Fentanyl

1.2.6 Other

1.3 Opioids Segment by Application

1.3.1 Global Opioids Market Value by Application: (2024-2030)

1.3.2 Pain Relief

1.3.3 Anesthesia

1.3.4 Cough Suppression

1.3.5 Diarrhea Suppression

1.3.6 Deaddiction

1.3.7 Others

1.4 Global Opioids Market Size Estimates and Forecasts

1.4.1 Global Opioids Revenue 2019-2030

1.4.2 Global Opioids Sales 2019-2030

1.4.3 Global Opioids Market Average Price (2019-2030)

1.5 Assumptions and Limitations

2 Opioids Market Competition by Manufacturers

2.1 Global Opioids Sales Market Share by Manufacturers (2019-2024)

2.2 Global Opioids Revenue Market Share by Manufacturers (2019-2024)

2.3 Global Opioids Average Price by Manufacturers (2019-2024)

2.4 Global Opioids Industry Ranking 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Opioids, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Opioids, Product Type & Application

2.7 Opioids Market Competitive Situation and Trends

2.7.1 Opioids Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest Opioids Players Market Share by Revenue

2.7.3 Global Opioids Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Opioids Retrospective Market Scenario by Region

3.1 Global Opioids Market Size by Region: 2019 Versus 2023 Versus 2030

3.2 Global Opioids Global Opioids Sales by Region: 2019-2030

3.2.1 Global Opioids Sales by Region: 2019-2024

3.2.2 Global Opioids Sales by Region: 2025-2030

3.3 Global Opioids Global Opioids Revenue by Region: 2019-2030

3.3.1 Global Opioids Revenue by Region: 2019-2024

3.3.2 Global Opioids Revenue by Region: 2025-2030

3.4 North America Opioids Market Facts & Figures by Country

3.4.1 North America Opioids Market Size by Country: 2019 VS 2023 VS 2030

3.4.2 North America Opioids Sales by Country (2019-2030)

3.4.3 North America Opioids Revenue by Country (2019-2030)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Opioids Market Facts & Figures by Country

3.5.1 Europe Opioids Market Size by Country: 2019 VS 2023 VS 2030

3.5.2 Europe Opioids Sales by Country (2019-2030)

3.5.3 Europe Opioids Revenue by Country (2019-2030)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Opioids Market Facts & Figures by Country

3.6.1 Asia Pacific Opioids Market Size by Country: 2019 VS 2023 VS 2030

3.6.2 Asia Pacific Opioids Sales by Country (2019-2030)

3.6.3 Asia Pacific Opioids Revenue by Country (2019-2030)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Opioids Market Facts & Figures by Country

3.7.1 Latin America Opioids Market Size by Country: 2019 VS 2023 VS 2030

3.7.2 Latin America Opioids Sales by Country (2019-2030)

3.7.3 Latin America Opioids Revenue by Country (2019-2030)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Opioids Market Facts & Figures by Country

3.8.1 Middle East and Africa Opioids Market Size by Country: 2019 VS 2023 VS 2030

3.8.2 Middle East and Africa Opioids Sales by Country (2019-2030)

3.8.3 Middle East and Africa Opioids Revenue by Country (2019-2030)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 U.A.E

4 Segment by Type

4.1 Global Opioids Sales by Type (2019-2030)

4.1.1 Global Opioids Sales by Type (2019-2024)

4.1.2 Global Opioids Sales by Type (2025-2030)

4.1.3 Global Opioids Sales Market Share by Type (2019-2030)

4.2 Global Opioids Revenue by Type (2019-2030)

4.2.1 Global Opioids Revenue by Type (2019-2024)

4.2.2 Global Opioids Revenue by Type (2025-2030)

4.2.3 Global Opioids Revenue Market Share by Type (2019-2030)

4.3 Global Opioids Price by Type (2019-2030)

5 Segment by Application

5.1 Global Opioids Sales by Application (2019-2030)

5.1.1 Global Opioids Sales by Application (2019-2024)

5.1.2 Global Opioids Sales by Application (2025-2030)

5.1.3 Global Opioids Sales Market Share by Application (2019-2030)

5.2 Global Opioids Revenue by Application (2019-2030)

5.2.1 Global Opioids Revenue by Application (2019-2024)

5.2.2 Global Opioids Revenue by Application (2025-2030)

5.2.3 Global Opioids Revenue Market Share by Application (2019-2030)

5.3 Global Opioids Price by Application (2019-2030)

6 Key Companies Profiled

6.1 Teva

6.1.1 Teva Corporation Information

6.1.2 Teva Description and Business Overview

6.1.3 Teva Opioids Sales, Revenue and Gross Margin (2019-2024)

6.1.4 Teva Opioids Product Portfolio

6.1.5 Teva Recent Developments/Updates

6.2 Purdue Pharma

6.2.1 Purdue Pharma Corporation Information

6.2.2 Purdue Pharma Description and Business Overview

6.2.3 Purdue Pharma Opioids Sales, Revenue and Gross Margin (2019-2024)

6.2.4 Purdue Pharma Opioids Product Portfolio

6.2.5 Purdue Pharma Recent Developments/Updates

6.3 Mallinckrodt

6.3.1 Mallinckrodt Corporation Information

6.3.2 Mallinckrodt Description and Business Overview

6.3.3 Mallinckrodt Opioids Sales, Revenue and Gross Margin (2019-2024)

6.3.4 Mallinckrodt Opioids Product Portfolio

6.3.5 Mallinckrodt Recent Developments/Updates

6.4 Amneal Pharma

6.4.1 Amneal Pharma Corporation Information

6.4.2 Amneal Pharma Description and Business Overview

6.4.3 Amneal Pharma Opioids Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Amneal Pharma Opioids Product Portfolio

6.4.5 Amneal Pharma Recent Developments/Updates

6.5 Collegium

6.5.1 Collegium Corporation Information

6.5.2 Collegium Description and Business Overview

6.5.3 Collegium Opioids Sales, Revenue and Gross Margin (2019-2024)

6.5.4 Collegium Opioids Product Portfolio

6.5.5 Collegium Recent Developments/Updates

6.6 J&J

6.6.1 J&J Corporation Information

6.6.2 J&J Description and Business Overview

6.6.3 J&J Opioids Sales, Revenue and Gross Margin (2019-2024)

6.6.4 J&J Opioids Product Portfolio

6.6.5 J&J Recent Developments/Updates

6.7 Endo

6.6.1 Endo Corporation Information

6.6.2 Endo Description and Business Overview

6.6.3 Endo Opioids Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Endo Opioids Product Portfolio

6.7.5 Endo Recent Developments/Updates

6.8 Pfizer

6.8.1 Pfizer Corporation Information

6.8.2 Pfizer Description and Business Overview

6.8.3 Pfizer Opioids Sales, Revenue and Gross Margin (2019-2024)

6.8.4 Pfizer Opioids Product Portfolio

6.8.5 Pfizer Recent Developments/Updates

6.9 INSYS

6.9.1 INSYS Corporation Information

6.9.2 INSYS Description and Business Overview

6.9.3 INSYS Opioids Sales, Revenue and Gross Margin (2019-2024)

6.9.4 INSYS Opioids Product Portfolio

6.9.5 INSYS Recent Developments/Updates

6.10 Mylan

6.10.1 Mylan Corporation Information

6.10.2 Mylan Description and Business Overview

6.10.3 Mylan Opioids Sales, Revenue and Gross Margin (2019-2024)

6.10.4 Mylan Opioids Product Portfolio

6.10.5 Mylan Recent Developments/Updates

6.11 Hikma

6.11.1 Hikma Corporation Information

6.11.2 Hikma Opioids Description and Business Overview

6.11.3 Hikma Opioids Sales, Revenue and Gross Margin (2019-2024)

6.11.4 Hikma Opioids Product Portfolio

6.11.5 Hikma Recent Developments/Updates

6.12 Egalet

6.12.1 Egalet Corporation Information

6.12.2 Egalet Opioids Description and Business Overview

6.12.3 Egalet Opioids Sales, Revenue and Gross Margin (2019-2024)

6.12.4 Egalet Opioids Product Portfolio

6.12.5 Egalet Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Opioids Industry Chain Analysis

7.2 Opioids Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Opioids Production Mode & Process

7.4 Opioids Sales and Marketing

7.4.1 Opioids Sales Channels

7.4.2 Opioids Distributors

7.5 Opioids Customers

8 Opioids Market Dynamics

8.1 Opioids Industry Trends

8.2 Opioids Market Drivers

8.3 Opioids Market Challenges

8.4 Opioids Market Restraints

9 Research Finding and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

List of Tables

Table 1. Global Opioids Market Value Comparison by Type (2024-2030) & (US$ Million)

Table 2. Global Opioids Market Value Comparison by Application (2024-2030) & (US$ Million)

Table 3. Global Opioids Market Competitive Situation by Manufacturers in 2023

Table 4. Global Opioids Sales (MT) of Key Manufacturers (2019-2024)

Table 5. Global Opioids Sales Market Share by Manufacturers (2019-2024)

Table 6. Global Opioids Revenue (US$ Million) by Manufacturers (2019-2024)

Table 7. Global Opioids Revenue Share by Manufacturers (2019-2024)

Table 8. Global Market Opioids Average Price (USD/Kg) of Key Manufacturers (2019-2024)

Table 9. Global Key Players of Opioids, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Opioids, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Opioids, Product Type & Application

Table 12. Global Key Manufacturers of Opioids, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Opioids by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Opioids as of 2023)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Opioids Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 17. Global Opioids Sales by Region (2019-2024) & (MT)

Table 18. Global Opioids Sales Market Share by Region (2019-2024)

Table 19. Global Opioids Sales by Region (2025-2030) & (MT)

Table 20. Global Opioids Sales Market Share by Region (2025-2030)

Table 21. Global Opioids Revenue by Region (2019-2024) & (US$ Million)

Table 22. Global Opioids Revenue Market Share by Region (2019-2024)

Table 23. Global Opioids Revenue by Region (2025-2030) & (US$ Million)

Table 24. Global Opioids Revenue Market Share by Region (2025-2030)

Table 25. North America Opioids Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 26. North America Opioids Sales by Country (2019-2024) & (MT)

Table 27. North America Opioids Sales by Country (2025-2030) & (MT)

Table 28. North America Opioids Revenue by Country (2019-2024) & (US$ Million)

Table 29. North America Opioids Revenue by Country (2025-2030) & (US$ Million)

Table 30. Europe Opioids Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 31. Europe Opioids Sales by Country (2019-2024) & (MT)

Table 32. Europe Opioids Sales by Country (2025-2030) & (MT)

Table 33. Europe Opioids Revenue by Country (2019-2024) & (US$ Million)

Table 34. Europe Opioids Revenue by Country (2025-2030) & (US$ Million)

Table 35. Asia Pacific Opioids Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 36. Asia Pacific Opioids Sales by Region (2019-2024) & (MT)

Table 37. Asia Pacific Opioids Sales by Region (2025-2030) & (MT)

Table 38. Asia Pacific Opioids Revenue by Region (2019-2024) & (US$ Million)

Table 39. Asia Pacific Opioids Revenue by Region (2025-2030) & (US$ Million)

Table 40. Latin America Opioids Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Latin America Opioids Sales by Country (2019-2024) & (MT)

Table 42. Latin America Opioids Sales by Country (2025-2030) & (MT)

Table 43. Latin America Opioids Revenue by Country (2019-2024) & (US$ Million)

Table 44. Latin America Opioids Revenue by Country (2025-2030) & (US$ Million)

Table 45. Middle East & Africa Opioids Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 46. Middle East & Africa Opioids Sales by Country (2019-2024) & (MT)

Table 47. Middle East & Africa Opioids Sales by Country (2025-2030) & (MT)

Table 48. Middle East & Africa Opioids Revenue by Country (2019-2024) & (US$ Million)

Table 49. Middle East & Africa Opioids Revenue by Country (2025-2030) & (US$ Million)

Table 50. Global Opioids Sales (MT) by Type (2019-2024)

Table 51. Global Opioids Sales (MT) by Type (2025-2030)

Table 52. Global Opioids Sales Market Share by Type (2019-2024)

Table 53. Global Opioids Sales Market Share by Type (2025-2030)

Table 54. Global Opioids Revenue (US$ Million) by Type (2019-2024)

Table 55. Global Opioids Revenue (US$ Million) by Type (2025-2030)

Table 56. Global Opioids Revenue Market Share by Type (2019-2024)

Table 57. Global Opioids Revenue Market Share by Type (2025-2030)

Table 58. Global Opioids Price (USD/Kg) by Type (2019-2024)

Table 59. Global Opioids Price (USD/Kg) by Type (2025-2030)

Table 60. Global Opioids Sales (MT) by Application (2019-2024)

Table 61. Global Opioids Sales (MT) by Application (2025-2030)

Table 62. Global Opioids Sales Market Share by Application (2019-2024)

Table 63. Global Opioids Sales Market Share by Application (2025-2030)

Table 64. Global Opioids Revenue (US$ Million) by Application (2019-2024)

Table 65. Global Opioids Revenue (US$ Million) by Application (2025-2030)

Table 66. Global Opioids Revenue Market Share by Application (2019-2024)

Table 67. Global Opioids Revenue Market Share by Application (2025-2030)

Table 68. Global Opioids Price (USD/Kg) by Application (2019-2024)

Table 69. Global Opioids Price (USD/Kg) by Application (2025-2030)

Table 70. Teva Corporation Information

Table 71. Teva Description and Business Overview

Table 72. Teva Opioids Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)

Table 73. Teva Opioids Product

Table 74. Teva Recent Developments/Updates

Table 75. Purdue Pharma Corporation Information

Table 76. Purdue Pharma Description and Business Overview

Table 77. Purdue Pharma Opioids Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)

Table 78. Purdue Pharma Opioids Product

Table 79. Purdue Pharma Recent Developments/Updates

Table 80. Mallinckrodt Corporation Information

Table 81. Mallinckrodt Description and Business Overview

Table 82. Mallinckrodt Opioids Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)

Table 83. Mallinckrodt Opioids Product

Table 84. Mallinckrodt Recent Developments/Updates

Table 85. Amneal Pharma Corporation Information

Table 86. Amneal Pharma Description and Business Overview

Table 87. Amneal Pharma Opioids Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)

Table 88. Amneal Pharma Opioids Product

Table 89. Amneal Pharma Recent Developments/Updates

Table 90. Collegium Corporation Information

Table 91. Collegium Description and Business Overview

Table 92. Collegium Opioids Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)

Table 93. Collegium Opioids Product

Table 94. Collegium Recent Developments/Updates

Table 95. J&J Corporation Information

Table 96. J&J Description and Business Overview

Table 97. J&J Opioids Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)

Table 98. J&J Opioids Product

Table 99. J&J Recent Developments/Updates

Table 100. Endo Corporation Information

Table 101. Endo Description and Business Overview

Table 102. Endo Opioids Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)

Table 103. Endo Opioids Product

Table 104. Endo Recent Developments/Updates

Table 105. Pfizer Corporation Information

Table 106. Pfizer Description and Business Overview

Table 107. Pfizer Opioids Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)

Table 108. Pfizer Opioids Product

Table 109. Pfizer Recent Developments/Updates

Table 110. INSYS Corporation Information

Table 111. INSYS Description and Business Overview

Table 112. INSYS Opioids Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)

Table 113. INSYS Opioids Product

Table 114. INSYS Recent Developments/Updates

Table 115. Mylan Corporation Information

Table 116. Mylan Description and Business Overview

Table 117. Mylan Opioids Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)

Table 118. Mylan Opioids Product

Table 119. Mylan Recent Developments/Updates

Table 120. Hikma Corporation Information

Table 121. Hikma Description and Business Overview

Table 122. Hikma Opioids Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)

Table 123. Hikma Opioids Product

Table 124. Hikma Recent Developments/Updates

Table 125. Egalet Corporation Information

Table 126. Egalet Description and Business Overview

Table 127. Egalet Opioids Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)

Table 128. Egalet Opioids Product

Table 129. Egalet Recent Developments/Updates

Table 130. Key Raw Materials Lists

Table 131. Raw Materials Key Suppliers Lists

Table 132. Opioids Distributors List

Table 133. Opioids Customers List

Table 134. Opioids Market Trends

Table 135. Opioids Market Drivers

Table 136. Opioids Market Challenges

Table 137. Opioids Market Restraints

Table 138. Research Programs/Design for This Report

Table 139. Key Data Information from Secondary Sources

Table 140. Key Data Information from Primary Sources

List of Figures

Figure 1. Product Picture of Opioids

Figure 2. Global Opioids Market Value Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Opioids Market Share by Type in 2023 & 2030

Figure 4. Oxycodone Product Picture

Figure 5. Hydromorphone Product Picture

Figure 6. Codeine Product Picture

Figure 7. Fentanyl Product Picture

Figure 8. Other Product Picture

Figure 9. Global Opioids Market Value Comparison by Application (2024-2030) & (US$ Million)

Figure 10. Global Opioids Market Share by Application in 2023 & 2030

Figure 11. Pain Relief

Figure 12. Anesthesia

Figure 13. Cough Suppression

Figure 14. Diarrhea Suppression

Figure 15. Deaddiction

Figure 16. Others

Figure 17. Global Opioids Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 18. Global Opioids Market Size (2019-2030) & (US$ Million)

Figure 19. Global Opioids Sales (2019-2030) & (MT)

Figure 20. Global Opioids Average Price (USD/Kg) & (2019-2030)

Figure 21. Opioids Report Years Considered

Figure 22. Opioids Sales Share by Manufacturers in 2023

Figure 23. Global Opioids Revenue Share by Manufacturers in 2023

Figure 24. The Global 5 and 10 Largest Opioids Players: Market Share by Revenue in 2023

Figure 25. Opioids Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023

Figure 26. Global Opioids Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Figure 27. North America Opioids Sales Market Share by Country (2019-2030)

Figure 28. North America Opioids Revenue Market Share by Country (2019-2030)

Figure 29. U.S. Opioids Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 30. Canada Opioids Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 31. Europe Opioids Sales Market Share by Country (2019-2030)

Figure 32. Europe Opioids Revenue Market Share by Country (2019-2030)

Figure 33. Germany Opioids Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 34. France Opioids Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 35. U.K. Opioids Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 36. Italy Opioids Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 37. Russia Opioids Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 38. Asia Pacific Opioids Sales Market Share by Region (2019-2030)

Figure 39. Asia Pacific Opioids Revenue Market Share by Region (2019-2030)

Figure 40. China Opioids Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 41. Japan Opioids Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 42. South Korea Opioids Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 43. India Opioids Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 44. Australia Opioids Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 45. Taiwan Opioids Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 46. Indonesia Opioids Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 47. Thailand Opioids Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 48. Malaysia Opioids Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 49. Philippines Opioids Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 50. Latin America Opioids Sales Market Share by Country (2019-2030)

Figure 51. Latin America Opioids Revenue Market Share by Country (2019-2030)

Figure 52. Mexico Opioids Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 53. Brazil Opioids Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 54. Argentina Opioids Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 55. Middle East & Africa Opioids Sales Market Share by Country (2019-2030)

Figure 56. Middle East & Africa Opioids Revenue Market Share by Country (2019-2030)

Figure 57. Turkey Opioids Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 58. Saudi Arabia Opioids Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 59. U.A.E Opioids Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 60. Global Sales Market Share of Opioids by Type (2019-2030)

Figure 61. Global Revenue Market Share of Opioids by Type (2019-2030)

Figure 62. Global Opioids Price (USD/Kg) by Type (2019-2030)

Figure 63. Global Sales Market Share of Opioids by Application (2019-2030)

Figure 64. Global Revenue Market Share of Opioids by Application (2019-2030)

Figure 65. Global Opioids Price (USD/Kg) by Application (2019-2030)

Figure 66. Opioids Value Chain

Figure 67. Opioids Production Process

Figure 68. Channels of Distribution (Direct Vs Distribution)

Figure 69. Distributors Profiles

Figure 70. Bottom-up and Top-down Approaches for This Report

Figure 71. Data Triangulation

Figure 72. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions